Achieving Consensus for Management of Hormone-Sensitive, Low-Volume Metastatic Prostate Cancer in Italy

Achieving Consensus for Management of Hormone-Sensitive, Low-Volume Metastatic Prostate Cancer in Italy

Metastatic hormone-sensitive prostate cancer (mHSPC) is usually categorized as high- or low-volume disease. This is relevant because low- and high-volume metastatic disease are associated with different outcomes, and thus management of the two forms should differ. Although some definitions have been...

Full description

Bibliographic Details
Main Authors: Elena Verzoni, Giovanni Pappagallo, Filippo Alongi, Stefano Arcangeli, Giulio Francolini, Daniele Galanti, Luca Galli, Marco Maruzzo, Sabrina Rossetti, Giambattista Siepe, Luca Triggiani, Paolo Andrea Zucali, Rolando Maria D’Angelillo
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Current Oncology
Subjects:
prostate
hormone-sensitive
low-volume
oligometastatic
ARTA
chemotherapy
Online Access:https://www.mdpi.com/1718-7729/29/7/362

Internet

https://www.mdpi.com/1718-7729/29/7/362

Similar Items